A Phase Ib dose finding study of fruquintinib in combination with Taxotere® in gastric cancer.

Trial Profile

A Phase Ib dose finding study of fruquintinib in combination with Taxotere® in gastric cancer.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 27 Sep 2016

At a glance

  • Drugs Docetaxel (Primary) ; Fruquintinib (Primary)
  • Indications Gastric cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 27 Sep 2016 New trial record
    • 02 Aug 2016 According to a Chi-Med media release, company is enrolling patients in this trial to expand the data-set.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top